We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canada Trails Similar Countries in Patient Access to New Drugs
Canada Trails Similar Countries in Patient Access to New Drugs
Canada lags significantly behind other developed countries in providing coverage for new medicines, with Canadians waiting on average 462 days for novel, potentially lifesaving drugs, a new report shows.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor